Sexual and Gender Minority Adults Have Higher Risk of Epilepsy
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, July 24, 2024 -- Sexual and gender minority adults in the United States have a disproportionate prevalence of epilepsy, according to a study published online July 22 in JAMA Neurology.
Emily L. Johnson, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues estimated the prevalence of active epilepsy among sexual and gender minority people in the United States. Analysis included 27,624 participants in the 2022 National Health Interview Survey.
The researchers found that active epilepsy was present in 1.2 percent of the population, overall. A higher proportion of sexual and gender minority adults reported active epilepsy (2.4 percent, versus 1.1 percent in non-sexual and gender minority adults). When adjusting for age, race, ethnicity, income, and education, the odds of epilepsy among sexual and gender minority people was more than doubled (adjusted odds ratio, 2.14).
"The findings suggest that the burden of epilepsy is high in people of sexual and gender minoritized groups, who are already at high risk of stigmatization, discrimination, and poor health outcomes," the authors write. "The reasons for this disparity are likely complex and may be associated with biological and psychosocial determinants of health unique to this population; as such, these individuals are in need of protected access to medical care."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-25 07:15
Read more
- AI Might Help Pick Up Heart Trouble in Dogs
- AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9
- Postpartum Exercise Cuts Odds of Postpartum Depression
- Big Post-Election Surge Seen in Online Sales of Morning-After Pills
- Risk for Mortality Up With Low Income in Type 2 Diabetes
- Bystanders More Readily Perform CPR If 911 Operator Instructs
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions